Abstract:BACKGROUND:Immunotherapy has demonstrated a limited clinical efficacy in approximately 5% of cholangiocarcinoma. The main challenges for an effective immunotherapy response in cholangiocarcinoma arise from the tumor microenvironment, which is poorly understood.METHODS:For a comprehensive analysis of the tumor microenvironment in cholangiocarcinoma, we performed multiplex immunohistochemistry with two 15-marker immune panels and Nanostring assays for a comprehensive analysis of 104 surgically resected cholangiocarcinomas including intrahepatic, hilar, and distal cholangiocarcinoma. We also validated some key findings with a batch integration analysis of published single cell RNA sequencing data.RESULTS:This study found that natural killer cells occupy the largest immune cell compartment in cholangiocarcinoma. Granzyme-B+CD8+ effector T cells are significantly associated with better overall survival in both intrahepatic and distal cholangiocarcinoma. Above 85% of intrahepatic cholangiocarcinomas with higher density of PD-1-EOMES-CD8+ effector T cells are associated with long-term survival. However, only the density of PD-1-EOMES-CD8+ T cells in the tumor areas, but not in the peripheries of the tumors, is prognostic. In all three cholangiocarcinoma subtypes, T regulator cells are significantly associated with a poor prognosis; however, M1 and M2 tumor-associated macrophages or PD-L1+ tumor-associated macrophage demonstrate different prognostic values. Combining PD-L1+ M1 or M2, PD-L1- M1 or M2 tumor-associated macrophages, and T regulator cells to subgroup intrahepatic and distal cholangiocarcinoma, the prognosis is significantly better distinguished. Moreover, PD-L1- M2 tumor-associated macrophages is associated with a good prognosis in intrahepatic and distal cholangiocarcinoma, suggesting this subtype of M2 tumor-associated macrophages may be antitumoral. Interestingly, lower densities of various types of immunosuppressive cells are associated with decreased infiltration of effector T cells in distal and hilar cholangiocarcinoma, but not in intrahepatic cholangiocarcinoma. In intrahepatic cholangiocarcinoma, PD-L1+ tumor-associated macrophages exert their immunosuppressive function likely through promoting T cell exhaustion.CONCLUSIONS:This study suggests that the densities of Granzyme-B+CD8+ effector T cells and non-exhausted PD-1-EOMES-CD8+ T cells and the PD-L1 status in the tumor-associated macrophages are prognostic makers in cholangiocarcinomas. The study also supports targeting PD-L1+ tumor-associated macrophages as the immunotherapy for cholangiocarcinoma.

The Expression of Smad4,TGF-β_1 and TβR II Protein in Cholangiocarcinoma

Expression of pGSK-3α/β (Tyr279/216) and XIAP proteins in cholangiocarcinoma and their clinical significance

Immune Cell Atlas of Cholangiocarcinomas Reveals Distinct Tumor Microenvironments and Associated Prognoses.

Expression of TGF-β_1,TGF-β TypeII Receptor and Smad4 Protein in Colorectal Cancer Tissues

Overexpressions of Ck2 Beta and Xiap Are Associated with Poor Prognosis of Patients with Cholangiocarcinoma

Overexpressions of CK2β and XIAP Are Associated with Poor Prognosis of Patients with Cholangiocarcinoma

Expression of TGF-β1, TβRII and Smad4 in Colorectal Carcinoma

Expression and Significance of Smad4mrna,tgf-Β1 ,and TGF-βR1 in Pancreatic Carcinoma

The Clinicopathological Significance of Transforming Growth Factor-Β1, Transforming Growth Factor-Β1 Receptor Ⅱ ,smad4 and Smad7

[Smad4 and TGF-beta1 Expression and Clinical Significance in Bladder Transitional Cell Carcinoma].

Expressions of TGFβ1/Smads Proteins in Breast Cancer Tissues and Their Clinical Significances

[Correlations of TGF-betaRII, Smad4 and Smad7 Expression to Clinicopathologic Characteristics and Prognosis of Gastric Cancer].

Expression of TGF-β1 and Smad2 in human gastric cancer

Correlation of Between Expressions of COX-2 and VEGF in Cholangiocarcinama

Expressions and Clinical Significance of TGF-β1, MMP-2 in Gallbladder Carcinoma

Study on the expression of GSCs marker and it′s regulated factor in benign and malignant gallbladder lesions

The Expressions of HMGA2 and Thy1 in Extrahepatic Cholangiocarcinoma and Their Clinicopathological Significances

Expressions of VEGF,ANG-1,ANG-2 and TSP-1 in Cholangiocellular Carcinoma and Relationship with Tumor Angiogenesis,differentiation,invasion and Metastasis

Expression of Smad4, TβR II and P21waf1 in esophageal squamous cancer tissue and its biological significance

Correlations of Caspase-3, Bcl-2/Bax Protein Expressions with Clinical Pathological Features of Cholangiocarcinoma

Expressions of ECHS1 and PKM2 proteins in cholangiocarcinoma and the clinical significance